SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biosource International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Howard who wrote ()7/28/1997 10:35:00 PM
From: Peter H. Mack   of 696
 
The 2nd quarter was announced after the close of the market today.
I am not encouraged by the news.
What the data shows is a significant percentage increase in everything except net income.
Although there was a pre-announcement of 15% revenue shortfall
due to exchange rates, sales and G&A expenses seem to be much higher.

3 month Jun-97 3 month Jun-96
Revenue 5,044,416 100.00% 3,262,638 100.00%
cost of gds. 1,784,613 35.38% 1,138,107 34.88%
R&D 524,075 10.39% 289,484 8.87%
Sales,Market 1,017,547 20.17% 508,752 15.59%
G&A 839,121 16.63% 443,050 13.58%
net income 772,435 15.31% 590,900 18.11%

Is anyone aware of a conference call following this announcement??
Anyone care to comment??

regards
pete mack
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext